• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Seroprevalence study in Vojvodina (Serbia) following 2009 pandemic influenza A(H1N1)V

tetano

Editor, Senior Moderator
Srp Arh Celok Lek. 2012 Nov-Dec;140(11-12):751-5.
Seroprevalence study in Vojvodina (Serbia) following 2009 pandemic influenza A(H1N1)V.
Petrović V, Reguljev Z, Nedeljković J, Ristić M.
Source

Centre for Disease Control and Prevention, Institute of Public Health of Vojvodina, Novi Sad, Serbia. vladimir.petrovic@izjzv.org.rs
Abstract
INTRODUCTION:

The seroprevalence study was performed in Vojvodina during May and June 2010 in order to asses the effects of the 2009 pandemic influenza A(H1N1)v epidemic on herd immunity. It was a part of the Serbian Ministry of Health funded nationwide study.
OBJECTIVE:

Prevalence of antibodies against 2009 pandemic influenza A(H1N1)v was determined in a 1% sample of the population monitored for influenza-like illness and acute respiratory infections in Vojvodina through sentinel surveillance system.
METHODS:

The study sample involved a total of 1004 inhabitants of Vojvodina. The control group consisted of randomly selected and age-adjusted 1054 sera collected in the pre-pandemic period. Sera were tested by the reaction of hemagglutination inhibition using influenza A/California/7/2009 (H1N1) antigen in dilution from 1:8 to 1:256. Antibody titers > or = 1:32 and > or = 1:8 were considered protective and diagnostic, respectively.
RESULTS:

The differences between control and study sera in all age groups were significant for both diagnostic > or = 1/8 and protective titres > or = 1/32 of hemagglutination inhibition antibodies (chi square test, p < 0.001). The highest percentage of seropositive subjects was registered in the age group 15-19 years followed by children aged 5-14 years. Both diagnostic and protective titres were about twice higher in the vaccinated as compared to the non-vaccinated group. There were no statistically significant differences in seroprevalence between seven districts of Vojvodina.
CONCLUSION:

The 2009 pandemic influenza A(H1N1)v epidemic significantly influenced the herd immunity in our population regardless of low immunization coverage with highest immunity levels in adolescents aged 15-19 years and with similar herd immunity levels in all the regions in the province six months after the outbreak.

PMID:
23350250
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23350250
 
Back
Top Bottom